This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner you agree to the use of cookies.

Technical Statistical Marketing

Show preferences Accept all

CONTINUUS Pharmaceuticals Raises $5 M in Series B Round, Led by Mark Bamforth Who Will Join the Board of Directors

This round was led by Mark Bamforth, President & CEO at Arranta Bio, with participation by IMA Industria Macchine Automatiche and other investors from previous rounds. Bamforth will also join the Board of Directors of CONTINUUS, bringing decades of experience in commercial pharmaceutical manufacturing.

Find the full press release here

Request Information

Phone: (781) 281-0115 Main Office

Email: [email protected]